TransplantID Journal
@TheTxIDjournal
Followers
6K
Following
701
Media
105
Statuses
773
The TID journal targets experts who study, diagnose, treat & prevent infectious complications in SOT, HCT & Heme/Onc patients #TxID #transplant #IDtwitter
Joined February 2021
Consider applying for as an editor of @TheTxIDjournal! If you have specific questions, please send them to tidedjournal@gmail.com. 4/4
0
0
0
If you are interested, please send a cover letter (no more than 2 pages) that discusses your interest in the role and your experience in thoracic transplantation as well as your current CV. Please send these two documents to tidedjournal@gmail.com by October 17, 2025. 3/4
1
0
0
Ideally, the candidate will be based in North America, although candidates from any region are invited to apply. The role involves joining quarterly editorial meetings (1 hr), handling a ~1 new paper/week to organize reviewers and make acceptance decisions. 2/4
1
0
0
@TheTxIDjournal is seeking applications for those interested in joining the editorial team ( https://t.co/AZP3ApjjKU) as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT and/or Oncology ID for this position. 1/4
1
1
5
We are always looking for people willing to be reviewers for the journal - we have developed this survey to let you tell us if you are willing to be a reviewer and what topics you’d like to review on for @TheTxIDjournal! @AST_IDCOP @ttsorg
https://t.co/jZXhgbgWgc
docs.google.com
The Transplant Infectious Disease Journal is looking for reviewers for the journal and to get more details about our current reviewers. As such, if you are interested in helping the Journal with...
0
2
9
So excited to see this CPC out from @JennCuellarR and colleagues from @NIAIDNews about a case of Acanthamoeba in an HSCT recipient. Exemplary case and great work finding the potential source. https://t.co/bBQXND0Ba3
onlinelibrary.wiley.com
Acanthamoeba infection in HCT recipients, represent multiple challenges. Early diagnosis, and effective treatment, remain the main barriers to survival. High index of suspicion, may help in identif...
0
9
20
@monicaslavin Lastly, we are also excited to welcome @benwteh as our newest Associate Editor with a focus on Onc ID/HSCT ID. Please help me in congratulating Ben on joining the editorial leadership team!
0
0
5
We also want to thank @monicaslavin for her hard work and dedication as an Associate Editor and editor responsible for reviews. Monica is going to rotate off as associate editor and join our editorial board. Please help me in thanking Monica!
1
0
5
As the year comes to an end its an opportunity to acknowledge all who have contributed to @TheTxIDjournal and to recognize changes in our editorial team. We thank all of the reviewers and outline the key accomplishments of the journal in 2024 here: https://t.co/ba0MSpwmY6
onlinelibrary.wiley.com
Click on the article title to read more.
1
2
14
A fantastic Special Edition with some great papers in @TheTxIDjournal
So excited to have the Donor-Derived Infection Special Edition out - thanks to @StephaniePouch and @karenmjwaller for being guest editors for this special edition! https://t.co/UIX0gWhTHd
0
1
6
So excited to have the Donor-Derived Infection Special Edition out - thanks to @StephaniePouch and @karenmjwaller for being guest editors for this special edition! https://t.co/UIX0gWhTHd
onlinelibrary.wiley.com
Click on the title to browse this issue
0
9
31
This award is named after Bob Rubin, one of the early leaders in the field of #TxID. He was also the first editor of @TheTxIDjournal. He was passionate about defining the optimal approach to prevention and management of infections in ICHs.
0
0
0
Congratulations to @nischalr3 and his team for their paper being selected as the @TheTxIDjournal 2024 Bob Rubin Clinical Impact Awardee - this award selects the paper felt to have the biggest impact on clinical care in #TxID! Congrats! https://t.co/9tP3g8kIpS
onlinelibrary.wiley.com
In the management of immunocompromised patients with neutropenia and Gram-negative bloodstream infection, short antimicrobial courses (≤10 days) had comparable propensity score-adjusted 90-day...
4
9
40
Kidney txp safe for patients on #tuberculosis treatment? @TheTxIDjournal series 30 pt in India suggests yes! 2+ mos. RIPE➡️txp➡️rifamycin-free (quinolone) regimen 👍pt & graft survival! Added by @AneelaMajeed5 ORGANISMS▶️BACTERIA▶️TUBERCULOSIS📂 https://t.co/WjgddJt41u
0
11
20
Reminder - we will are looking for a new Associate Editor focused of HSCT/Oncology ID - see Tweet for detail - please submit CV and cover letter to tidedjournal@gmail.com by November 8.
@TheTxIDjournal is seeking applications for those interested in joining the editorial team as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position. https://t.co/AZP3ApiLVm
0
2
3
Most recent issue is out for @TheTxIDjournal - lots of great papers but 3 focused on allergies: A paper on the impact of sulfa-allergy labels on infection outcome & an experiences from the field about implementing delabeling from @TrubianoJason et al https://t.co/da7oucrfTc
onlinelibrary.wiley.com
Click on the title to browse this issue
0
2
8
Deadline is approaching!
As the end of the year approaches, consider applying for the AJT Editorial Fellowship Program. The Editorial Fellowship is a year-long editorial experience in the publication and peer review process to fellows and junior faculty in transplant-related fields.
0
2
5
Want to learn the current state of the art for prevention of RVI in immunocompromised patients? Join us for the next @ESCMID ESGICH/@esgrev_escmid webinar on the prevention of RVI. Chaired by Elisa Cordero, Barbara Rath Talks by @nesherl @MichaelGIsonMD @@JoshuaHillMD
2
8
35
We continue to move papers previously rejected at other journals through quickly! Got a paper that was rejected at another journal - consider @TheTxIDjournal instead of other journals. Its free and we’ll get your a decision generally within a few weeks.
@TheTxIDjournal is pleased to announce that we are now accepting papers rejected from other journals with expedited review. As opposed to some journals that charge over $3000/article, there is no publication fee @TheTxIDjournal. https://t.co/Zmx0SmwKtQ
0
2
3
Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark your calendars for May 11-14, 2025, for the 5th symposium on infections in immunocompromised individuals. Travel stipends available!
0
12
55